• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Report: Biomarkers market to grow 18.5% by 2018

Report: Biomarkers market to grow 18.5% by 2018

October 4, 2013
CenterWatch Staff

A biomarker is an identifiable and measurable characteristic that identifies the severity and/or occurrence of a specific disease. It has applications in the discovery and development of novel therapeutic drugs. The global biomarkers market shows a high growth potential and accounts for $17.5 billion in 2013. And it is expected to grow at a Compound Annual Growth Rate (CAGR) of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018, according to a report by RnRMarketResearch.com, an online database of market research reports.

The major drivers slated to propel the growth of this market include advancements in discovery technologies, high demand from the indications of various diseases, increasing partnerships and collaborations to boost biomarker research, increase in government and private sector investments and funds for biomarker discovery, FDA support for biomarker development and increasing utility of biomarkers in patient stratification and drug development. However, a few pivotal factors, such as the high capital investment and low benefit-cost ratio, cumbersome biomarker validation procedure and difficulty in sample collection and its storage, are expected to hamper growth of this market.

The global market has been segmented into discovery technologies, services, applications and disease indications. The biomarker discovery technology market has been further segmented into omics technology, imaging technology and bioinformatics. The omics technology segment accounts for the largest share, primarily due to the increase in adoption of proteomics and genomics technologies across the globe.

In addition, the biomarker services (sample preparation, assay development and biomarker validation and testing) and applications (drug discovery and formulation and development of molecular diagnostics and personalized medicine) markets also are included in the report. The drug discovery and development segment holds the largest share of biomarker applications market, attributed to the potential of biomarkers to reduce the length of clinical trials, ultimately decreasing the overall cost of the entire drug discovery and development process.

By type of disease, the global biomarkers market is further classified as oncology, cardiology, neurology and other diseases (HIV, renal disorders, diabetes, arthritis and tuberculosis). Oncology biomarkers account for the lion's share of the biomarker disease indication market, and this market is forecast to grow at the highest growth rate in the next five years, being stimulated by the increasing need for the early diagnosis of tumor cells. Oncology biomarkers enhance the screening and early detection of cancer as well as facilitate the high-speed, non-invasive cancer diagnosis procedure.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing